Review on Additives in Hydrogels for 3D Bioprinting of Regenerative Medicine: From Mechanism to Methodology

Wenzhuo Fang, Ming–Hsuan Yang, Meng Liu, Yangwang Jin, Yuhui Wang, Ranxing Yang, Ying Wang, Kaile Zhang, Qiang FuPharmaceutics 2023 · DOI

TL;DR

3D bioprinting holds immense promise for regenerative medicine, but current bioinks (hydrogels) often fall short in crucial areas like vascularization, infection control, and tissue remodeling. This review meticulously categorizes and analyzes various additives incorporated into these hydrogels, detailing their mechanisms and methodologies to enhance tissue regeneration and provide a roadmap for future research.

What Problem Does This Paper Address?

The ultimate goal of regenerative medicine is to repair or replace damaged tissues and organs. While 3D bioprinting offers a revolutionary approach to creating complex, functional tissue constructs, the "bioinks" used – typically hydrogels loaded with cells – face significant hurdles. These challenges include:

  • Insufficient Vascularization: New tissues need a robust blood supply to deliver nutrients and oxygen and remove waste. Without it, tissues can become ischemic and hypoxic, leading to failure.
  • Infection Risk: Implanted materials are susceptible to bacterial colonization, forming biofilms that evade the immune system and antibiotics, leading to implant failure and complications.
  • Poor Tissue Integration and Remodeling: The body's natural healing processes, including inflammation, collagen deposition, and scar formation, can be negatively impacted by implants, hindering proper tissue regeneration.

To overcome these limitations, researchers are exploring the incorporation of various "additives" into hydrogel bioinks. This review aims to systematically organize and critically evaluate these additives, focusing on how they function at a mechanistic level and how they are practically implemented in 3D bioprinting strategies.

Methods

This paper is a comprehensive review, not an experimental study. The authors systematically searched and analyzed existing literature on additives used in 3D bioprinting for regenerative medicine. They categorized these additives based on their primary function in promoting tissue regeneration:

  • Vascularization: Additives that promote blood vessel formation.
  • Antibacterial: Additives that prevent or eliminate bacterial infections.
  • Immunomodulation: Additives that regulate the body's immune response, often by reducing inflammation.
  • Regulation of Collagen Deposition: Additives that influence how the body builds and remodels its own structural proteins.

For each additive, the authors describe its underlying mechanism of action and the methodologies employed in 3D bioprinting to incorporate it into hydrogel scaffolds. They also cite specific examples from the literature where these additives have been successfully applied.

Datasets

Not discussed in the paper. This is a review article that synthesizes existing research rather than presenting new experimental data or datasets.

Key Insights and Ideas

  • Multifunctionality is Key: Many additives exhibit multiple beneficial effects. For instance, certain metal ions can be both antibacterial and immunomodulatory, and extracellular matrix components can promote vascularization while also aiding collagen deposition. This suggests a future where single additives can address multiple regenerative medicine challenges.
  • Controlled Release is Crucial: The efficacy of many additives, particularly growth factors, is highly dependent on their controlled and sustained release from the hydrogel scaffold. This prevents rapid degradation and ensures a prolonged therapeutic effect.
  • Bioink Design is a Balancing Act: The ideal bioink needs to balance printability, biocompatibility, mechanical properties, and the specific biological functions imparted by additives. This often involves complex formulations and fabrication techniques.
  • The Microenvironment Matters: The success of 3D bioprinted constructs is not solely dependent on the scaffold itself but also on its interaction with the host tissue's microenvironment. Additives can help tailor this interaction.
  • From Lab to Clinic is a Long Road: While numerous promising additives and strategies exist in animal models and in vitro studies, their translation to human clinical applications remains a significant challenge, requiring careful consideration of site-specific needs and potential immunogenicity.

Key Results

The review details a wide array of additives and their reported effects:

  • Growth Factors (e.g., VEGF, FGF-2, PDGF): Shown to significantly enhance vascularization, cell proliferation, and tissue regeneration in various models. For example, VEGF-loaded scaffolds demonstrated much higher blood vessel density in rat cranial defects.
  • Antibacterial Agents (e.g., Silver Ions, Vancomycin, Levofloxacin): Effectively inhibit bacterial growth and biofilm formation. Silver nanoparticles, for instance, showed significant zones of inhibition against common bacteria.
  • Immunomodulatory Agents (e.g., Dexamethasone, Curcumin, Quercetin): Help balance inflammatory responses, shifting macrophages towards a pro-regenerative M2 phenotype and reducing pro-inflammatory cytokines. Curcumin-loaded scaffolds significantly inhibited TNF-α and IL-1 expression.
  • Collagen-Related Additives (e.g., Collagen itself, Extracellular Matrix): Directly influence the deposition and remodeling of collagen, crucial for tissue structure and integrity, leading to improved mechanical strength and reduced scar formation.

Limitations and Future Work

  • Limitations:
    • Many studies are still in the preclinical (animal) or in vitro stages, with limited translation to human clinical trials.
  • The long-term effects and potential immunogenicity of some additives, particularly those derived from animal sources (like dECM), require further investigation.
  • Achieving site-specific functionality and balancing multiple desired properties in a single scaffold remains a complex challenge.
  • Future Work:
    • Develop additives that can achieve multiple functions simultaneously, simplifying scaffold design and improving efficiency.
  • Tailor additive selection and incorporation strategies to the specific requirements of different implantation sites and tissue types.
  • Focus on translating promising preclinical findings into clinical applications, addressing challenges related to scalability, cost-effectiveness, and regulatory approval.
  • Further explore the intricate mechanisms by which additives interact with host cells and tissues to optimize regenerative outcomes.

Summary updated

Abstract

The regeneration of biological tissues in medicine is challenging, and 3D bioprinting offers an innovative way to create functional multicellular tissues. One common way in bioprinting is bioink, which is one type of the cell-loaded hydrogel. For clinical application, however, the bioprinting still suffers from satisfactory performance, e.g., in vascularization, effective antibacterial, immunomodulation, and regulation of collagen deposition. Many studies incorporated different bioactive materials into the 3D-printed scaffolds to optimize the bioprinting. Here, we reviewed a variety of additives added to the 3D bioprinting hydrogel. The underlying mechanisms and methodology for biological regeneration are important and will provide a useful basis for future research.
BibTeX
@inproceedings{fang2023review,
  author = {Wenzhuo Fang and Ming–Hsuan Yang and Meng Liu and Yangwang Jin and Yuhui Wang and Ranxing Yang and Ying Wang and Kaile Zhang and Qiang Fu},
  title = {{Review on Additives in Hydrogels for 3D Bioprinting of Regenerative Medicine: From Mechanism to Methodology}},
  booktitle = {Pharmaceutics},
  year = {2023},
  doi = {10.3390/pharmaceutics15061700},
}
Figure